<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39399920</PMID><DateRevised><Year>2024</Year><Month>11</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-8978</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><Issue>14</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>14</Day></PubDate></JournalIssue><Title>Psychological medicine</Title><ISOAbbreviation>Psychol Med</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 infection and the risk of depressive symptoms: a retrospective longitudinal study from the population-based CONSTANCES cohort.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>10</EndPage><MedlinePgn>1-10</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1017/S0033291724002435</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Should COVID-19 have a direct impact on the risk of depression, it would suggest specific pathways for prevention and treatment. In this retrospective population-based study, we aimed to examine the association of prior SARS-CoV-2 infection with depressive symptoms, distinguishing self-reported <i>v</i>. biologically confirmed COVID-19.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">32 007 participants from the SAPRIS survey nested in the French CONSTANCES cohort were included. COVID-19 was measured as followed: <i>ad hoc</i> serologic testing, self-reported PCR or serology positive test results, and self-reported COVID-19. Depressive symptoms were measured with the Center of Epidemiologic Studies-Depression Scale (CES-D). Outcomes were depressive symptoms (total CES-D score, its four dimensions, and clinically significant depressive symptoms) and exposure was prior COVID-19 (no COVID-19/self-reported unconfirmed COVID-19/biologically confirmed COVID-19).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In comparison to participants without COVID-19, participants with self-reported unconfirmed COVID-19 and biologically confirmed COVID-19 had higher CES-D scores (<i>&#x3b2;</i> for one interquartile range increase [95% CI]: 0.15 [0.08-0.22] and 0.09 [0.05-0.13], respectively) and somatic complaints dimension scores (0.15 [0.09-0.21] and 0.10 [0.07-0.13]). Only those with self-reported but unconfirmed COVID-19 had higher depressed affect dimension scores (0.08 [0.01-0.14]). Accounting for <i>ad hoc</i> serologic testing only, the CES-D score and the somatic complaints dimension were only associated with the combination of self-reported COVID-19 and negative serology test results.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The association between COVID-19 and depressive symptoms was merely driven by somatic symptoms of depression and did not follow a gradient consistent with the hypothesis of a direct impact of SARS-CoV-2 infection on the risk of depression.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pignon</LastName><ForeName>Baptiste</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-0526-3136</Identifier><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9;, Paris Saclay University, Universit&#xe9; de Versailles Saint-Quentin-en-Yvelines, INSERM, UMS 011 &#xab; Population-based Cohorts Unit &#xbb;, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiernik</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9;, Paris Saclay University, Universit&#xe9; de Versailles Saint-Quentin-en-Yvelines, INSERM, UMS 011 &#xab; Population-based Cohorts Unit &#xbb;, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranque</LastName><ForeName>Brigitte</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Service de M&#xe9;decine interne, AP-HP, H&#xf4;pital europ&#xe9;en Georges-Pompidou, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9; and Universit&#xe9; Sorbonne Paris Nord, Inserm, INRAE, Center for Research in Epidemiology and StatisticS (CRESS), Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robineau</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Inserm, Institut Pierre-Louis d'Epid&#xe9;miologie et de Sant&#xe9; Publique, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>EA2694, Univ Lille, Centre Hospitalier de Tourcoing, Tourcoing, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carrat</LastName><ForeName>Fabrice</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Inserm, Institut Pierre-Louis d'Epid&#xe9;miologie et de Sant&#xe9; Publique, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partement de sant&#xe9; publique, AP-HP, H&#xf4;pital Saint-Antoine, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Severi</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris-Saclay, UVSQ, INSERM, CESP U1018, Gustave Roussy, Villejuif, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Statistics, Computer Science, Applications 'G. Parenti,' University of Florence, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Touvier</LastName><ForeName>Mathilde</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sorbonne Paris Nord University, Inserm U1153, Inrae U1125, Cnam, Nutritional Epidemiology Research Team (EREN), Centre of Research in Epidemiology and Statistics (CRESS) - Universit&#xe9; Paris Cit&#xe9; (CRESS), Bobigny, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gouraud</LastName><ForeName>Cl&#xe9;ment</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9; and Universit&#xe9; Sorbonne Paris Nord, Inserm, INRAE, Center for Research in Epidemiology and StatisticS (CRESS), Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de Psychiatrie de l'adulte, AP-HP, H&#xf4;pital H&#xf4;tel-Dieu, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ouazana Vedrines</LastName><ForeName>Charles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9; and Universit&#xe9; Sorbonne Paris Nord, Inserm, INRAE, Center for Research in Epidemiology and StatisticS (CRESS), Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de Psychiatrie de l'adulte, AP-HP, H&#xf4;pital H&#xf4;tel-Dieu, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pitron</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9;, VIFASOM (Vigilance Fatigue Sommeil et Sant&#xe9; Publique), Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre du Sommeil et de la Vigilance-Pathologie professionnelle, APHP, H&#xf4;tel-Dieu, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoertel</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9;, INSERM U1266, Institut de Psychiatrie et Neuroscience de Paris, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de Psychiatrie et Addictologie, AP-HP, H&#xf4;pital Corentin-Celton, DMU Psychiatrie et Addictologie, Issy-les-Moulineaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kab</LastName><ForeName>Sofiane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9;, Paris Saclay University, Universit&#xe9; de Versailles Saint-Quentin-en-Yvelines, INSERM, UMS 011 &#xab; Population-based Cohorts Unit &#xbb;, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tebeka</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9;, INSERM U1266, Institut de Psychiatrie et Neuroscience de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldberg</LastName><ForeName>Marcel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9;, Paris Saclay University, Universit&#xe9; de Versailles Saint-Quentin-en-Yvelines, INSERM, UMS 011 &#xab; Population-based Cohorts Unit &#xbb;, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zins</LastName><ForeName>Marie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9;, Paris Saclay University, Universit&#xe9; de Versailles Saint-Quentin-en-Yvelines, INSERM, UMS 011 &#xab; Population-based Cohorts Unit &#xbb;, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lemogne</LastName><ForeName>C&#xe9;dric</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9; and Universit&#xe9; Sorbonne Paris Nord, Inserm, INRAE, Center for Research in Epidemiology and StatisticS (CRESS), Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de Psychiatrie de l'adulte, AP-HP, H&#xf4;pital H&#xf4;tel-Dieu, Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Psychol Med</MedlineTA><NlmUniqueID>1254142</NlmUniqueID><ISSNLinking>0033-2917</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">depression</Keyword><Keyword MajorTopicYN="N">depressive symptoms</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">persistent symptoms</Keyword><Keyword MajorTopicYN="N">post-COVID-19 condition</Keyword></KeywordList><CoiStatement>Dr Robineau reported personal fees and nonfinancial support from Gilead, ViiV Healthcare, and Merck Sharp &amp; Dohme Corp outside the submitted work. Dr Pitron reported personal fees from Grunenthal, outside the submitted work. Dr Lemogne reported non-financial support from Nordic Pharma, outside the submitted work. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>16</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>16</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>7</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39399920</ArticleId><ArticleId IdType="pmc">PMC11578902</ArticleId><ArticleId IdType="doi">10.1017/S0033291724002435</ArticleId><ArticleId IdType="pii">S0033291724002435</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ballering, A. V., van Zon, S. K. R., olde Hartman, T. C., &amp; Rosmalen, J. G. M. (2022). Persistence of somatic symptoms after COVID-19 in the Netherlands: An observational cohort study. The Lancet, 400(10350), 452&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Benros, M. E., Waltoft, B. L., Nordentoft, M., &#xd8;stergaard, S. D., Eaton, W. W., Krogh, J., &amp; Mortensen, P. B. (2013). Autoimmune diseases and severe infections as risk factors for mood disorders: A nationwide study. JAMA Psychiatry, 70(8), 812&#x2013;820.</Citation><ArticleIdList><ArticleId IdType="pubmed">23760347</ArticleId></ArticleIdList></Reference><Reference><Citation>Bottemanne, H., Delaigue, F., &amp; Lemogne, C. (2021). SARS-CoV-2 psychiatric sequelae: An urgent need of prevention. Frontiers in Psychiatry, 12, 738696.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8458863</ArticleId><ArticleId IdType="pubmed">34566731</ArticleId></ArticleIdList></Reference><Reference><Citation>Decio, V., Pirard, P., Pignon, B., Bouaziz, O., Perduca, V., Chin, F., &#x2026; Tebeka, S. (2022). Hospitalization for COVID-19 is associated with a higher risk of subsequent hospitalization for psychiatric disorders: A French nationwide longitudinal study comparing hospitalizations for COVID-19 and for other reasons. European Psychiatry, 65(1), e70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9677447</ArticleId><ArticleId IdType="pubmed">36266739</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud, G., Lee, S., Alfaro-Almagro, F., Arthofer, C., Wang, C., McCarthy, P., &#x2026; Smith, S. M. (2022). SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature, 604(7907), 697&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrat, F., de Lamballerie, X., Rahib, D., Blanch&#xe9;, H., Lapidus, N., Artaud, F., &#x2026; for the SAPRIS and SAPRIS-SERO Study Groups. (2021). Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: A multicohort study. International Journal of Epidemiology, 50(5), 1458&#x2013;1472.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8344948</ArticleId><ArticleId IdType="pubmed">34293141</ArticleId></ArticleIdList></Reference><Reference><Citation>Geoffroy, P. A., Decio, V., Pirard, P., Bouaziz, O., Corruble, E., Kovess-Masfety, V., &#x2026; Tebeka, S. (2024). Lower risk of hospitalisation for depression following hospitalisation for COVID-19 versus for another reason. Journal of Affective Disorders, 350, 332&#x2013;339. doi: 10.1016/j.jad.2024.01.121</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2024.01.121</ArticleId><ArticleId IdType="pubmed">38228275</ArticleId></ArticleIdList></Reference><Reference><Citation>Gleeson, M., Bishop, N. C., Stensel, D. J., Lindley, M. R., Mastana, S. S., &amp; Nimmo, M. A. (2011). The anti-inflammatory effects of exercise: Mechanisms and implications for the prevention and treatment of disease. Nature Reviews. Immunology, 11(9), 607&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pubmed">21818123</ArticleId></ArticleIdList></Reference><Reference><Citation>Granerod, J., Davies, N. W. S., Ramanuj, P. P., Easton, A., Brown, D. W. G., &amp; Thomas, S. L. (2017). Increased rates of sequelae post-encephalitis in individuals attending primary care practices in the United Kingdom: A population-based retrospective cohort study. Journal of Neurology, 264(2), 407&#x2013;415.</Citation><ArticleIdList><ArticleId IdType="pubmed">27766471</ArticleId></ArticleIdList></Reference><Reference><Citation>Han, Y., Yuan, K., Wang, Z., Liu, W.-J., Lu, Z.-A., Liu, L., &#x2026; Lu, L. (2021). Neuropsychiatric manifestations of COVID-19, potential neurotropic mechanisms, and therapeutic interventions. Translational Psychiatry, 11(1), 1&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8482959</ArticleId><ArticleId IdType="pubmed">34593760</ArticleId></ArticleIdList></Reference><Reference><Citation>Hart, B. L. (1988). Biological basis of the behavior of sick animals. Neuroscience and Biobehavioral Reviews, 12(2), 123&#x2013;137.</Citation><ArticleIdList><ArticleId IdType="pubmed">3050629</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawthorne, G., Hawthorne, G., &amp; Elliott, P. (2005). Imputing cross-sectional missing data: Comparison of common techniques. Australian &amp; New Zealand Journal of Psychiatry, 39(7), 583&#x2013;590.</Citation><ArticleIdList><ArticleId IdType="pubmed">15996139</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes, E. A., O'Connor, R. C., Perry, V. H., Tracey, I., Wessely, S., Arseneault, L., &#x2026; Bullmore, E. (2020). Multidisciplinary research priorities for the COVID-19 pandemic: A call for action for mental health science. The Lancet. Psychiatry, 7(6), 547&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159850</ArticleId><ArticleId IdType="pubmed">32304649</ArticleId></ArticleIdList></Reference><Reference><Citation>Irwin, M. R., Olmstead, R., &amp; Carroll, J. E. (2016). Sleep disturbance, sleep duration, and inflammation: A systematic review and meta-analysis of cohort studies and experimental sleep deprivation. Biological Psychiatry, 80(1), 40&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4666828</ArticleId><ArticleId IdType="pubmed">26140821</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein, J., Wood, J., Jaycox, J., Dhodapkar, R. M., Lu, P., Gehlhausen, J. R., &#x2026; Iwasaki, A. (2023). Distinguishing features of long COVID identified through immune profiling. Nature, 623, 139&#x2013;148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;hler-Forsberg, O., Petersen, L., Gasse, C., Mortensen, P. B., Dalsgaard, S., Yolken, R. H., &#x2026; Benros, M. E. (2019). A nationwide study in Denmark of the association between treated infections and the subsequent risk of treated mental disorders in children and adolescents. JAMA Psychiatry, 76(3), 271&#x2013;279.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6439826</ArticleId><ArticleId IdType="pubmed">30516814</ArticleId></ArticleIdList></Reference><Reference><Citation>Leboyer, M., Berk, M., Yolken, R. H., Tamouza, R., Kupfer, D., &amp; Groc, L. (2016). Immuno-psychiatry: An agenda for clinical practice and innovative research. BMC Medicine, 14(1), 173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5084344</ArticleId><ArticleId IdType="pubmed">27788673</ArticleId></ArticleIdList></Reference><Reference><Citation>Liotta, E. M., Batra, A., Clark, J. R., Shlobin, N. A., Hoffman, S. C., Orban, Z. S., &amp; Koralnik, I. J. (2020). Frequent neurologic manifestations and encephalopathy-associated morbidity in COVID-19 patients. Annals of Clinical and Translational Neurology, 7(11), 2221&#x2013;2230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7664279</ArticleId><ArticleId IdType="pubmed">33016619</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund Berven, L., Selvakumar, J., Havdal, L., Stiansen-Sonerud, T., Einvik, G., Leegaard, T. M., &#x2026; Wyller, V. B. B. (2022). Inflammatory markers, pulmonary function, and clinical symptoms in acute COVID-19 among non-hospitalized adolescents and young adults. Frontiers in Immunology, 13. Retrieved from https://www.frontiersin.org/articles/10.3389/fimmu.2022.837288</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8864121</ArticleId><ArticleId IdType="pubmed">35222429</ArticleId></ArticleIdList></Reference><Reference><Citation>Matta, J., Robineau, O., Wiernik, E., Carrat, F., Severi, G., Touvier, M., &#x2026; Lemogne, C. (2023). Depression and anxiety before and at the beginning of the COVID-19 pandemic and incident persistent symptoms: A prospective population-based cohort study. Molecular Psychiatry, 28(10), 4261&#x2013;4271. doi: 10.1038/s41380-023-02179-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-023-02179-9</ArticleId><ArticleId IdType="pubmed">37464077</ArticleId></ArticleIdList></Reference><Reference><Citation>Morin, A. J. S., Moullec, G., Ma&#xef;ano, C., Layet, L., Just, J.-L., &amp; Ninot, G. (2011). Psychometric properties of the Center for Epidemiologic Studies Depression Scale (CES-D) in French clinical and nonclinical adults. Revue D'epidemiologie Et De Sante Publique, 59(5), 327&#x2013;340.</Citation><ArticleIdList><ArticleId IdType="pubmed">21925817</ArticleId></ArticleIdList></Reference><Reference><Citation>Orlovska, S., Vestergaard, C. H., Bech, B. H., Nordentoft, M., Vestergaard, M., &amp; Benros, M. E. (2017). Association of streptococcal throat infection with mental disorders: Testing key aspects of the PANDAS hypothesis in a nationwide study. JAMA Psychiatry, 74(7), 740&#x2013;746.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5710247</ArticleId><ArticleId IdType="pubmed">28538981</ArticleId></ArticleIdList></Reference><Reference><Citation>Pape, K., Tamouza, R., Leboyer, M., &amp; Zipp, F. (2019). Immunoneuropsychiatry &#x2013; novel perspectives on brain disorders. Nature Reviews. Neurology, 15(6), 317&#x2013;328.</Citation><ArticleIdList><ArticleId IdType="pubmed">30988501</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson, B. K., Guevara-Coto, J., Yogendra, R., Francisco, E. B., Long, E., Pise, A., &#x2026; Mora-Rodr&#xed;guez, R. A. (2021). Immune-based prediction of COVID-19 severity and chronicity decoded using machine learning. Frontiers in Immunology, 12, 700782.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8273732</ArticleId><ArticleId IdType="pubmed">34262570</ArticleId></ArticleIdList></Reference><Reference><Citation>Penninx, B. W. J. H., Benros, M. E., Klein, R. S., &amp; Vinkers, C. H. (2022). How COVID-19 shaped mental health: From infection to pandemic effects. Nature Medicine, 28(10), 2027&#x2013;2037.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9711928</ArticleId><ArticleId IdType="pubmed">36192553</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh, C., Darley, D. R., Wilson, D. B., Howe, A., Munier, C. M. L., Patel, S. K., &#x2026; Matthews, G. V. (2022). Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nature Immunology, 23(2), 210&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Pignon, B., Matta, J., Wiernik, E., Toussaint, A., Loewe, B., Robineau, O., &#x2026; Lemogne, C. (2024). Psychological burden associated with incident persistent symptoms and their evolution during the COVID-19 pandemic: A prospective population-based study. BMJ Mental Health, 27(1), e300907.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11021747</ArticleId><ArticleId IdType="pubmed">38490690</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers, J. P., Chesney, E., Oliver, D., Pollak, T. A., McGuire, P., Fusar-Poli, P., &#x2026; David, A. S. (2020). Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: A systematic review and meta-analysis with comparison to the COVID-19 pandemic. The Lancet. Psychiatry, 7(7), 611&#x2013;627.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Sah, P., Fitzpatrick, M. C., Zimmer, C. F., Abdollahi, E., Juden-Kelly, L., Moghadas, S. M., &#x2026; Galvani, A. P. (2021). Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis. Proceedings of the National Academy of Sciences of the United States of America, 118(34), e2109229118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8403749</ArticleId><ArticleId IdType="pubmed">34376550</ArticleId></ArticleIdList></Reference><Reference><Citation>Salje, H., Tran Kiem, C., Lefrancq, N., Courtejoie, N., Bosetti, P., Paireau, J., &#x2026; Cauchemez, S. (2020). Estimating the burden of SARS-CoV-2 in France. Science (New York, N.Y.), 369(6500), 208&#x2013;211. doi: 10.1126/science.abc3517</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc3517</ArticleId><ArticleId IdType="pmc">PMC7223792</ArticleId><ArticleId IdType="pubmed">32404476</ArticleId></ArticleIdList></Reference><Reference><Citation>Matta, J., Wiernik, E., Robineau, O., Carrat, F., Touvier, M., Severi, G., &#x2026; Sant&#xe9;, Pratiques, Relations et In&#xe9;galit&#xe9;s Sociales en Population G&#xe9;n&#xe9;rale Pendant la Crise COVID-19&#x2013;S&#xe9;rologie (SAPRIS-SERO) Study Group. (2022). Association of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms among French adults during the COVID-19 pandemic. JAMA Internal Medicine, 182(1), 19&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8576624</ArticleId><ArticleId IdType="pubmed">34747982</ArticleId></ArticleIdList></Reference><Reference><Citation>Robineau, O., Zins, M., Touvier, M., Wiernik, E., Lemogne, C., de Lamballerie, X., &#x2026; Sant&#xe9;, P., Relations et In&#xe9;galit&#xe9;s Sociales en Population G&#xe9;n&#xe9;rale Pendant la Crise COVID-19&#x2013;S&#xe9;rologie (SAPRIS-SERO) Study Group. (2022). Long-lasting symptoms after an acute COVID-19 infection and factors associated with their resolution. JAMA Network Open, 5(11), e2240985.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9647489</ArticleId><ArticleId IdType="pubmed">36350653</ArticleId></ArticleIdList></Reference><Reference><Citation>Sant&#xe9; Publique France. (2023). Coronavirus: Chiffres cl&#xe9;s et &#xe9;volution de la COVID-19 en France et dans le Monde. Retrieved 7 June 2024, from https://www.santepubliquefrance.fr/dossiers/coronavirus-covid-19/coronavirus-chiffres-cles-et-evolution-de-la-covid-19-en-france-et-dans-le-monde</Citation></Reference><Reference><Citation>Santomauro, D. F., Herrera, A. M. M., Shadid, J., Zheng, P., Ashbaugh, C., Pigott, D. M., &#x2026; Ferrari, A. J. (2021). Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. The Lancet, 398(10312), 1700&#x2013;1712.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8500697</ArticleId><ArticleId IdType="pubmed">34634250</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf;, C., Willscher, E., Paschold, L., Gottschick, C., Klee, B., Bosurgi, L., &#x2026; Binder, M. (2023). Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post-acute sequelae of COVID-19. Journal of Medical Virology, 95(1), e28364.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9878213</ArticleId><ArticleId IdType="pubmed">36458566</ArticleId></ArticleIdList></Reference><Reference><Citation>Shattuck, E. C., &amp; Muehlenbein, M. P. (2016). Towards an integrative picture of human sickness behavior. Brain, Behavior, and Immunity, 57, 255&#x2013;262.</Citation><ArticleIdList><ArticleId IdType="pubmed">27165989</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommen, S. L., Havdal, L. B., Selvakumar, J., Einvik, G., Leegaard, T. M., Lund-Johansen, F., &#x2026; Berven, L. L. (2022). Inflammatory markers and pulmonary function in adolescents and young adults 6 months after mild COVID-19. Frontiers in Immunology, 13, 1081718.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9853911</ArticleId><ArticleId IdType="pubmed">36685555</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet, M., Geddes, J. R., Husain, M., Luciano, S., &amp; Harrison, P. J. (2021a). 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: A retrospective cohort study using electronic health records. The Lancet Psychiatry, 8(5), 416&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet, M., Luciano, S., Geddes, J. R., &amp; Harrison, P. J. (2021b). Bidirectional associations between COVID-19 and psychiatric disorder: Retrospective cohort studies of 62 354 COVID-19 cases in the USA. The Lancet Psychiatry, 8(2), 130&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet, M., Sillett, R., Zhu, L., Mendel, J., Camplisson, I., Dercon, Q., &amp; Harrison, P. J. (2022). Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: An analysis of 2-year retrospective cohort studies including 1 284 437 patients. The Lancet. Psychiatry, 9(10), 815&#x2013;827.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Tebeka, S., Carcaillon-Bentata, L., Decio, V., Alleaume, C., Beltzer, N., Gallay, A., &#x2026; Coste, J. (2023). Complex association between post-COVID-19 condition and anxiety and depression symptoms. European Psychiatry: The Journal of the Association of European Psychiatrists, 67(1), e1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10964277</ArticleId><ArticleId IdType="pubmed">38088068</ArticleId></ArticleIdList></Reference><Reference><Citation>Davisse-Paturet, C., Orri, M., Legleye, S., Florence, A.-M., Hazo, J.-B., Warszawski, J., &#x2026; the EPICOV Study Group. (2023). Suicidal ideation following self-reported COVID-19-like symptoms or serology-confirmed SARS-CoV-2 infection in France: A propensity score weighted analysis from a cohort study. PLOS Medicine, 20(2), e1004171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10072374</ArticleId><ArticleId IdType="pubmed">36787340</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson, E. J., Stafford, J., Moltrecht, B., Huggins, C. F., Kwong, A. S. F., Shaw, R. J., &#x2026; Patalay, P. (2022). Psychological distress, depression, anxiety, and life satisfaction following COVID-19 infection: Evidence from 11 UK longitudinal population studies. The Lancet Psychiatry, 9(11), 894&#x2013;906.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9560745</ArticleId><ArticleId IdType="pubmed">36244359</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharaj, A., Thomas, N., Ellul, M. A., Davies, N. W. S., Pollak, T. A., Tenorio, E. L., &#x2026; Michael, B. D. (2020). Neurological and neuropsychiatric complications of COVID-19 in 153 patients: A UK-wide surveillance study. The Lancet. Psychiatry, 7(10), 875&#x2013;882.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7316461</ArticleId><ArticleId IdType="pubmed">32593341</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano, J. B., Murthy, S., Marshall, J. C., Relan, P., Diaz, J. V., &amp; WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. (2022). A clinical case definition of post-COVID-19 condition by a Delphi consensus. The Lancet. Infectious Diseases, 22(4), e102&#x2013;e107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang, Y.-T., Yang, Y., Li, W., Zhang, L., Zhang, Q., Cheung, T., &amp; Ng, C. H. (2020). Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed. The Lancet Psychiatry, 7(3), 228&#x2013;229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7128153</ArticleId><ArticleId IdType="pubmed">32032543</ArticleId></ArticleIdList></Reference><Reference><Citation>Zins, M., &amp; Goldberg, M. (2015). The French CONSTANCES population-based cohort: Design, inclusion and follow-up. European Journal of Epidemiology, 30, 1317&#x2013;1328.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4690834</ArticleId><ArticleId IdType="pubmed">26520638</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>